PharmaLundensis AB announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced operating loss was SEK 580,178 compared to SEK 729,802 a year ago. Net loss was SEK 674,748 compared to SEK 794,870 a year ago.